MYELODYSPLASTIC NEOPLASMS
Clinical trials for MYELODYSPLASTIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC NEOPLASMS trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offers hope for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called JNJ-89853413 for adults with acute myeloid leukemia or myelodysplastic neoplasms that have returned or stopped responding to previous treatments. The main goals are to find a safe dose and see how the body processes the drug. Re…
Matched conditions: MYELODYSPLASTIC NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First patients to receive experimental drug for aggressive blood cancers
Disease control Recruiting nowThis is the first study in humans to test a new drug called JNJ-90189892. It aims to find a safe and effective dose for adults whose acute myeloid leukemia or myelodysplastic syndrome has returned or not responded to prior treatments. The study will first determine the safest dos…
Matched conditions: MYELODYSPLASTIC NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC